Sales decline 16.70% to Rs 73.35 crore
Net Loss of Parenteral Drugs (India) reported to Rs 24.31 crore in the quarter ended June 2016 as against net loss of Rs 17.23 crore during the previous quarter ended June 2015. Sales declined 16.70% to Rs 73.35 crore in the quarter ended June 2016 as against Rs 88.05 crore during the previous quarter ended June 2015. ParticularsQuarter EndedJun. 2016Jun. 2015% Var.Sales73.3588.05 -17 OPM %-2.288.96 -PBDT-22.38-9.89 -126 PBT-28.33-16.65 -70 NP-24.31-17.23 -41Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
